Showing 759 news articles about Hepatitis C treatment

Filters Content type: Editors' picks Topic: Hepatitis C treatment

Direct-acting antiviral medicines interfere with different steps of the hepatitis C lifecycle. A combination of drugs may be co-formulated into a single pill. Modern treatment typically lasts for two or three months, usually does not cause side-effects and cures more than 95% of treated people.

Hepatitis C treatment

Australian NSP Survey National Data Report 2012 – 2016

Editor's pick
Kirby Institute
4 July 2017
Hepatitis C treatment

Charity calls for new focus to combat Hep C infections in Scotland

Editor's pick
BBC
27 June 2017
Hepatitis C treatment

Swiss hepatitis C sufferers to get full access to expensive drug

Editor's pick
swissinfo.ch
26 June 2017
New & experimental hepatitis C treatment

European CHMP Adopts Positive Opinion for Gilead’s Vosevi® (Sofosbuvir/Velpatasvir/Voxilaprevir) for the Treatment of All Chronic Hepatitis C Genotypes

Editor's pick
Gilead press release
26 June 2017
New & experimental hepatitis C treatment

AbbVie Receives CHMP Positive Opinion for MAVIRET™ (glecaprevir/pibrentasvir) for the Treatment of Chronic Hepatitis C in All Major Genotypes (GT1-6)

Editor's pick
AbbVie press release
26 June 2017
Hepatitis C treatment

Monitoring the Hepatitis C Epidemic in the United States: What Tools Are Needed to Acheive Elimination?

Editor's pick
O'Neill Institute, Georgetown University
20 June 2017
Hepatitis C treatment

Experts release new recommendations for the elimination of HCV in the U.S.

Editor's pick
Healio
20 June 2017
Hepatitis C treatment

Hepatitis C antiviral drugs are effective

Editor's pick
The Guardian
14 June 2017
Hepatitis C treatment

“Findings from hepatitis C study should not deter patients from seeking treatment or governments from funding it” says World Hepatitis Alliance

Editor's pick
World Hepatitis Alliance
13 June 2017
Hepatitis C treatment

The Hepatitis C Trust responds to Cochrane review on hepatitis C treatment

Editor's pick
Hepatitis C Trust
13 June 2017
Hepatitis C treatment

'Miracle' hepatitis C drugs costing £30k per patient 'may have no clinical effect'

Editor's pick
The Guardian
8 June 2017
Hepatitis C treatment

Swiss bend rules to provide patients with affordable treatment

Editor's pick
Swissinfo
5 June 2017
Hepatitis C treatment

China captures 12 smugglers of Indian pharmaceuticals

Editor's pick
Xinhua
24 May 2017
Hepatitis C treatment

Costs for generic hepatitis C drugs available in India would be paid back in 5 to 10 years

Editor's pick
Eurekalert Inf Dis
18 May 2017
Hepatitis C treatment

Surgeons plan to use hepatitis-infected hearts to slash wait for a transplant

Editor's pick
STAT
15 May 2017
Harm reduction

State HCV Incidence and Policies Related to Preventive Services, and Treatment Services for Persons Who Inject Drugs

Editor's pick
CDC
12 May 2017
New & experimental hepatitis C treatment

Early Access to Medicines Scheme (EAMS) Granted to AbbVie’s Investigational Pan-genotypic Regimen for Chronic Hepatitis C in UK

Editor's pick
AbbVie press release
10 May 2017
Hepatitis C treatment

BC-developed hepatitis C screening test personalizes treatment for patients

Editor's pick
The Globe and Mail
10 May 2017
Access to healthcare

Louisiana proposes tapping a century-old patent law to cut hepatitis C drug prices

Editor's pick
Washington Post
3 May 2017
Hepatitis C treatment

New website launched to help prevent spread of hepatitis C

Editor's pick
ModernHealthcare.com
28 April 2017
Pharmaceutical industry

Top 10 Pharmaceutical Companies 2017

Editor's pick
LinkedIn
18 April 2017
Access to healthcare

Hepatitis drug patent application opposed

Editor's pick
Bangkok Post
12 April 2017
Hepatitis C treatment

WHO prequalifies first generic active ingredient for hepatitis C medicines

Editor's pick
World Health Organization
5 April 2017
Hepatitis C treatment

Scale up of hepatitis C treatment possible as Brazil rejects patent on key drug

Editor's pick
MSF
3 April 2017